Activation of dendritic cells by oligonucleotides containing the CpG motif.

被引:0
作者
Ban, E [1 ]
Dupré, L [1 ]
Hermann, E [1 ]
Vendeville, C [1 ]
Quatannens, B [1 ]
Capron, A [1 ]
Riveau, G [1 ]
机构
[1] Inst Pasteur, INSERM, U167, F-59019 Lille, France
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
B33
引用
收藏
页码:37 / 37
页数:1
相关论文
共 50 条
  • [41] A dinucleotide motif in oligonucleotides shows potent immunomodulatory activity and overrides species-specific recognition observed with CpG motif
    Kandimalla, ER
    Bhagat, L
    Zhu, FG
    Yu, D
    Cong, YP
    Wang, DQ
    Tang, JX
    Tang, JY
    Knetter, CF
    Lien, E
    Agrawal, S
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) : 14303 - 14308
  • [42] Activation of p75 nerve growth factor receptor is blocked by cyclic peptides containing a lysine-glycine-alanine (KGA) motif.
    Zhai, S
    Traber, K
    Yaar, M
    Gilchrest, BA
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 481 - 481
  • [43] Anti-tumoral capabilities of effector cells after IFN-α or CpG-motif treatment of cocultured dendritic cells
    Erhardt, Michael
    Schmidt-Wolf, Ingo G. H.
    Sievers, Elisabeth
    Frank, Susanne
    Strehl, John
    von Lilienfeld-Toal, Marie
    Gorschlueter, Marcus
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2006, 54 (06) : 403 - 409
  • [44] Transient in vivo activation of rat brain macrophages/microglial cells and astrocytes by immunostimulatory multiple CpG oligonucleotides
    Schluesener, HJ
    Seid, K
    Deininger, M
    Schwab, J
    JOURNAL OF NEUROIMMUNOLOGY, 2001, 113 (01) : 89 - 94
  • [45] Anti-tumoral capabilities of effector cells after IFN-α or CpG-motif treatment of cocultured dendritic cells
    Michael Erhardt
    Ingo G. H. Schmidt-Wolf
    Elisabeth Sievers
    Susanne Frank
    John Strehl
    Marie von Lilienfeld-Toal
    Marcus Gorschlüter
    Archivum Immunologiae et Therapiae Experimentalis, 2006, 54 : 403 - 409
  • [46] Effect of Head and Neck Cancer Supernatant and CpG-Oligonucleotides on Migration and IFN-α Production of Plasmacytoid Dendritic Cells
    Thiel, Annette
    Pries, Ralph
    Jeske, Sabrina
    Trenkle, Thomas
    Wollenberg, Barbara
    ANTICANCER RESEARCH, 2009, 29 (08) : 3019 - 3025
  • [47] Immunotherapy with dendritic cells and CpG oligonucleotides can be combined with chemotherapy without loss of efficacy in a mouse model of colon cancer
    Bourquin, C
    Schreiber, S
    Beck, S
    Hartmann, G
    Endres, S
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (11) : 2790 - 2795
  • [48] Thermolytic CpG-containing DNA oligonucleotides as potential immunotherapeutic prodrugs
    Grajkowski, A
    Pedras-Vasconcelos, J
    Wang, VV
    Ausín, C
    Hess, S
    Verthelyi, D
    Beaucage, SL
    NUCLEIC ACIDS RESEARCH, 2005, 33 (11) : 3550 - 3560
  • [49] Introduction of sugar-modified nucleotides into CpG-containing antisense oligonucleotides inhibits TLR9 activation
    Yoshida, Tokuyuki
    Hagihara, Tomoko
    Uchida, Yasunori
    Horiuchi, Yoshiyuki
    Sasaki, Kiyomi
    Yamamoto, Takenori
    Yamashita, Takuma
    Goda, Yukihiro
    Saito, Yoshiro
    Yamaguchi, Takao
    Obika, Satoshi
    Yamamoto, Seiji
    Inoue, Takao
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [50] DNA binding by an L-2-quinoxalylalanine-containing tandem beta-turn peptide motif.
    Huang, XF
    Dobbins, JR
    Murali, N
    Long, EC
    BIOCHEMISTRY, 1996, 35 (28) : 14 - 14